MapLight Therapeutics, Inc. (MPLT)
17.76
-0.12
(-0.67%)
USD |
NASDAQ |
Feb 23, 12:44
MapLight Therapeutics SG&A Expense (Quarterly) : 4.404M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CDT Equity, Inc. | 5.501M |
| LENZ Therapeutics, Inc. | 27.60M |
| Liminatus Pharma, Inc. | 0.7012M |
| Oruka Therapeutics, Inc. | 5.117M |
| Maze Therapeutics, Inc. | 7.775M |